CRL

#968
Charles River Laboratories International, Inc.
182.1400 USD
+0.86%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
181.2585
182.4050
Yıllık Aralık
146.4900
228.8800
Günlük Değişim
+0.86%
Aylık Değişim
+17.89%
6 Aylık Değişim
-7.47%
Yıllık Değişim
-7.47%
Önceki Kapanış
180.5850
Açılış
181.9450
Bid
Ask
Düşük
181.2585
High
182.4050
Hacim
13
Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler
Çeyreklik Yıllık
  • Market Capitalization 8.9664 B
  • Employee 20 K
  • Founded N/A
  • CEO James C. Foster
  • Website www.criver.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000BG5BL8
  • Industry Tanı ve Araştırma
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Total debt
Free cash flow
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-69.81
Price to sales ratio
2.51

Charles River Laboratories International Inc

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients. Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs. As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL.

Haberler